
zzso zzso are involved in every step of zzso The development of zzso agents zzso has provided the ability to fight cancer by reversing these zzso Currently, four zzso have been approved for cancer zzso two DNA zzso agents and two zzso zzso A number of promising zzso are undergoing clinical trials in several cancer zzso Moreover, already approved zzso are still under clinical investigation to improve their efficacy and to extend their use to a broader panel of zzso zzso treatments with zzso are already considered a promising strategy to improve clinical benefits and to limit side zzso The real mechanisms by which these zzso allow the improvement and zzso of patients are still zzso A deeper analysis of the molecular features expressed by responding patients should be performed to reveal this zzso In this review, we focus on clinical trials with zzso discussing the success and the pitfalls of this new class of zzso zzso 

